Atlas Trials

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Clinical trial NCT07232706 · RECRUITING

Trial details

NCT number
NCT07232706
Sponsor
Centre Hospitalier Annecy Genevois
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
RSV Immunization
Start date
2026-05-06
Primary completion
2029-05-05
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.